Conmed CORP 8-K filings

CONMED Corporation announced a 4.5% increase in second-quarter sales but lowered its full-year revenue and earnings guidance due to ongoing supply chain challenges.

CONMED Corporation has announced the retirement of its Vice President, Corporate Controller, Terence M. Berge, and the promotion of Eric B. Staves to the role, effective July 1, 2024.

CONMED Corporation held its annual meeting, electing eight directors, approving executive compensation, ratifying its accounting firm, and declaring a $0.20 per share quarterly dividend.

CONMED Corporation has announced the promotion of Pat Beyer to Chief Operating Officer and the transition of Heather Cohen to a Special Advisor role, effective April 20, 2024.

CONMED Corporation announced a 5.7% year-over-year increase in sales for the first quarter of 2024, alongside an adjusted earnings per share increase of 19.7%, while also adjusting its full-year revenue and earnings guidance due to currency headwinds.

CONMED Corporation's Board of Directors has declared a quarterly cash dividend of $0.20 per share.

CONMED Corporation announced robust financial results for the fourth quarter and full-year 2023, marked by significant revenue growth and improved earnings per share.